BW-2258U89

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameBW-2258U89
Drug Alias Name2258U89BW2258U89BW-10
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBombesin receptor antagonists
TargetsBombesin receptor
Therapy Area/IndicationsFeeding and Eating DisordersNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsFeeding and Eating DisordersNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A